SCHEMBL2171627

SCHEMBL2171627

O=C(NCCCCC(NC(=O)C1CCCN1C(=O)C(CC1CCCCC1)NC(=O)c1ccc2ccccc2c1)B(O)O)NC1CCCCC1

nearest known ligand 0.80

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
HTRA1 Q92743 20/20 0.80

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29750922 1.00 HTRA1 (0.80) HTRA1
SCHEMBL17859941 0.90 HTRA1 (0.99) HTRA1
SCHEMBL17860098 0.89 HTRA1 (0.98) HTRA1
SCHEMBL17860095 0.88 HTRA1 (1.00) HTRA1
SCHEMBL21536000 0.79 HTRA1 (0.81) HTRA1
SCHEMBL17843424 0.79 HTRA1 (0.84) HTRA1
SCHEMBL19746109 0.78 HTRA1 (0.79) HTRA1
SCHEMBL30334878 0.78 HTRA1 (0.79) HTRA1
SCHEMBL19746107 0.78 HTRA1 (0.79) HTRA1
SCHEMBL19745348 0.77 HTRA1 (0.59) HTRA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7972787-B2 determining whether the subject has a protective variant and/or a risk variant at a polymorphic site in the HTRA1 gene; slowing the progression by reducing the expression of the HTRA1 gene, or reducing the biological activity of the HTRA1 gene product MASSACHUSETTS EYE AND EAR INFIRMARY (US) 2011-07-05 US disclosed